Not exact matches
Pattern of employment and associated factors in long - term lymphoma survivors 10 years
after high - dose chemotherapy with
autologous stem cell transplantation.
A national study on conditional survival, excess mortality and second cancer
after high dose therapy with
autologous stem cell transplantation for non-Hodgkin lymphoma.
Conditional survival and excess mortality
after high - dose therapy with
autologous stem cell transplantation for adult refractory or relapsed Hodgkin lymphoma in Norway.
Hematopoietic
stem cells express the markers CD34 and CD133 and can repopulate a myeloablated recipient
after allogeneic or
autologous transplantation.